To irradiate or electroporate: how should we ablate pancreatic cancer?
- PMID: 40337766
- PMCID: PMC12056099
- DOI: 10.21037/tgh-24-164
To irradiate or electroporate: how should we ablate pancreatic cancer?
Keywords: Pancreatic cancer; irreversible electroporation (IRE); locally advanced pancreatic adenocarcinoma (LAPC); stereotactic ablative body radiation therapy (SABR therapy); stereotactic body radiation therapy (SBRT).
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tgh.amegroups.com/article/view/10.21037/tgh-24-164/coif). The authors have no conflicts of interest to declare.
Comment on
-
MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial.Lancet Gastroenterol Hepatol. 2024 May;9(5):448-459. doi: 10.1016/S2468-1253(24)00017-7. Epub 2024 Mar 19. Lancet Gastroenterol Hepatol. 2024. PMID: 38513683 Clinical Trial.
References
-
- Howlader N, Noone AM, Krapcho M, et al. editors. SEER Cancer Statistics Review, 1975–2017. National Cancer Institute. Bethesda, MD. 2020.
-
- Bryant JM, Palm RF, Liveringhouse C, et al. Surgical and Pathologic Outcomes of Pancreatic Adenocarcinoma (PA) After Preoperative Ablative Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy (A-SMART). Adv Radiat Oncol 2022;7:101045. 10.1016/j.adro.2022.101045 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources